Skip to Main Content

Author Details

Pietro Invernizzi
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
1996
336
69
PMIDPaper TitleJournal TitlePublished Year
33267568Open challenges in the management of autoimmune hepatitis.Minerva Gastroenterol (Torino)2023
37386786Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Hepatology2023
33300753Risk stratification in primary sclerosing cholangitis.Minerva Gastroenterol (Torino)2023
34266794The application of artificial intelligence in hepatology: A systematic review.Dig Liver Dis2022
35431507Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.World J Gastroenterol2022
35566783Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?J Clin Med2022
36612000The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.Cancers (Basel)2022
36150526Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.Gastroenterology2022
36059513Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis.Front Immunol2022
36157547Clinical challenge for gastroenterologists-Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review.World J Gastroenterol2022
34951722Machine learning in primary biliary cholangitis: A novel approach for risk stratification.Liver Int2022
34873918Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.Immunotherapy2022
35203339Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study.Cells2022
34523800Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.Clin Transl Sci2022
34608663E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants.Hepatology2022
34838993The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence.Nanomedicine2022
34716542Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study.Endocrine2022
32978808DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.Hepatology2021
33681748Real-world experience with obeticholic acid in patients with primary biliary cholangitis.JHEP Rep2021
33651317Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.J Endocrinol Invest2021
33764590Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis.Aliment Pharmacol Ther2021
33713486Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study.Hepatology2021
33678471Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"â¿¿ (J Hepatol [2020] 505-515).J Hepatol2021
33645508Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study.Dig Liver Dis2021
33925355Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.Int J Mol Sci2021
33724515Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.Hepatology2021
33554101Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison.J Transl Autoimmun2021
34588749Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.World J Gastroenterol2021
34629807Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.World J Gastroenterol2021
34542229Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know.Liver Int2021
34834519MEDTEC Students against Coronavirus: Investigating the Role of Hemostatic Genes in the Predisposition to COVID-19 Severity.J Pers Med2021
34303876The genetic architecture of primary biliary cholangitis.Eur J Med Genet2021
33936120Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis.Front Immunol2021
34354803Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literature.World J Gastrointest Surg2021
33069497Reply to: "A spotlight on natural killer cells in primary biliary cholangitis".J Hepatol2021
33323757Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.Eur J Gastroenterol Hepatol2021
33440073The seat of life. What a lesson from the stigmatized saints.Liver Int2021
32777554Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis.Clin Gastroenterol Hepatol2021
32830065Cost of illness of Primary Biliary Cholangitis - a population-based study.Dig Liver Dis2021
32789729Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.Dig Dis Sci2021
31419573Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis.Clin Gastroenterol Hepatol2020
31937871Correction to: Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes.Lab Invest2020
31813755Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study.Dig Liver Dis2020
31757316Individualizing Care: Management Beyond Medical Therapy.Surg Oncol Clin N Am2020
31843787Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.Gut2020
32076457Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis".Dis Markers2020
31863485Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment?Hepatology2020
31892505Understanding short bowel syndrome: Current status and future perspectives.Dig Liver Dis2020
31771820Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies.Ann Hepatol2020
33425946Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ⿤2 cm: Study Protocol for a Prospective Observational Study.Front Med (Lausanne)2020
  • 1 - 50 of 336

Recommended Authors

Min Kyu Kang
Yeungnam University College of Medicine
Career Start Year 2018
Number of shared co-authors 0
Bryan M McCauley
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2016
Number of shared co-authors 4
Khashayar Asadi
Austin Hospital
Career Start Year 2015
Number of shared co-authors 0
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 7
Neil Rajoriya
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 1
Christopher Koh
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 0
Bita V Naini
university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 0
Jung Gil Park
Yeungnam University Hospital
Career Start Year 2006
Number of shared co-authors 0
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 1
Elie Aoun
Columbia University
Career Start Year 2002
Number of shared co-authors 0
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Career Start Year 2001
Number of shared co-authors 4
Curtis K Argo
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 3
Jayant A Talwalkar
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 2
Frank Tacke
Charite-Universitatsmedizin Berlin
Career Start Year 1999
Number of shared co-authors 0
Ariel E Feldstein
University of California San Diego
Career Start Year 1997
Number of shared co-authors 0
Michael P Curry
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1997
Number of shared co-authors 0
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 1
Peter St??rkel
Cliniques Universitaires Saint-Luc (CUSL)
Career Start Year 1996
Number of shared co-authors 0
James E Squires
UPMC Children's Hospital of Pittsburgh.
Career Start Year 1995
Number of shared co-authors 0
Andrew D Clouston
University of Queensland
Career Start Year 1993
Number of shared co-authors 0
Hector Melin-Aldana
Ann & Robert H. Lurie Children's Hospital of Chicago
Career Start Year 1990
Number of shared co-authors 0
Christine M Hunt
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 0
Arun J Sanyal
Virginia Commonwealth University
Career Start Year 1989
Number of shared co-authors 2
Grace L Su
University of Washington
Career Start Year 1989
Number of shared co-authors 0
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 4
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 0
Terry M Therneau
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 5
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Career Start Year 1975
Number of shared co-authors 2
Ronald J Sokol
Digestive Health Institute, Children's Hospital Colorado
Career Start Year 1964
Number of shared co-authors 0

Collaborators

Merrill Eric Gershwin
Allergy and Clinical Immunology, University of California at Davis
Co-authored papers 93
Ana Lleo
Humanitas University
Co-authored papers 56
Gideon M Hirschfield
University of Toronto
Co-authored papers 33
Ross L Coppel
Nursing and Health SciencesMonash UniversityClaytonVictoriaAustralia.
Co-authored papers 16
Michael F Seldin
University of California davis
Co-authored papers 11
George F Mells
University of Cambridge
Co-authored papers 10
Andre Franke
Institute of Clinical Molecular Biology, Kiel University
Co-authored papers 8
Konstantinos N Lazaridis
Mayo Clinic
Co-authored papers 8
Brian D Juran
Mayo Clinic
Co-authored papers 7
Richard N Sandford
University of Cambridge
Co-authored papers 6
Daniele Prati
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico
Co-authored papers 5
Katherine A Siminovitch
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 5
Christopher I Amos
Baylor College of Medicine
Co-authored papers 5
Ruqi Tang
Co-authored papers 4
Carl A Anderson
Wellcome Sanger Institute
Co-authored papers 4
Heather J Cordell
Population Health Sciences Institute, Newcastle University
Co-authored papers 4
Rosanna Asselta
Co-authored papers 4
Daniele Cusi
Institute of Biomedical Technologies, National Research Council of Italy
Co-authored papers 4
David Ellinghaus
Co-authored papers 4
Stefan Schreiber
Co-authored papers 3
Peter K Gregersen
Co-authored papers 3
Gang Xie
Chaohu Hospital Affiliated to Anhui Medical University
Co-authored papers 3
Domenica Taruscio
National Center for Rare Diseases, Istituto Superiore di Sanita
Co-authored papers 2
Yafang Li
University of Michigan ann arbor
Co-authored papers 2
Michael Wittig
Co-authored papers 2
Wolfgang Lieb
Co-authored papers 2
Stefano Duga
Co-authored papers 2
Elizabeth J Atkinson
Mayo Clinic
Co-authored papers 2
Cisca Wijmenga
Co-authored papers 2
Mariza de Andrade
Mayo Clinic
Co-authored papers 2
Release 1.2